The Anti-Candida Vaccine Based on the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis

We have previously shown that vaccination with a vaccine based on the recombinant N-terminal domain of Als1p (rAls1p-N) protected BALB/c mice against disseminated infection caused by a single strain of Candida albicans (A. S. Ibrahim, B. J. Spellberg, V. Avenissian, Y. Fu, S. G. Filler, and J. E. Ed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ibrahim, Ashraf S., Spellberg, Brad J., Avanesian, Valentina, Fu, Yue, Edwards, John E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2006
Assuntos:
Fungal and Parasitic Infections
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1459699/
https://ncbi.nlm.nih.gov/pubmed/16622247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.74.5.3039-3041.2006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados